文献速递肝胆胰外科围术期管理与 ERAS

单中心50余年2500例胰腺移植的演变

Evolution of Pancreas Transplantation At A Single Institution-50+ Years and 2500 Transplants.
PubMed 文献 · Ann Surg · 2024-06-25

该单中心回顾性研究分析了50余年间2500例胰腺移植的演变,按6个时代划分。患者和移植物生存率逐代改善;最近时代10年死亡删失胰腺移植物生存率SPK为86.9%、PAK为58.2%、PTA为47.6%。改善因素包括首次移植、膀胱引流、年轻供者和更短保存时间。

要点

  • 胰腺移植 outcomes 随时代显著改善,SPK 最优。
  • 最近时代10年 death-censored 胰腺移植物生存率 SPK 86.9%、PAK 58.2%、PTA 47.6%。
  • 首次移植、膀胱引流、年轻供者、短保存时间与更好移植物生存相关。

核心结论

  • 胰腺移植 outcomes 通过手术技术、免疫抑制方案、缩短保存时间和减少免疫介导移植物丢失而显著改善。

研究设计与样本

  • 单中心回顾性综述,纳入50余年间2500例胰腺移植,采用双变量和多变量模型分析,按6个时代划分。

主要发现

  • 所有患者和移植物生存指标在6个移植时代中逐步改善。
  • 总体死亡删失胰腺移植物半衰期:SPK >35年,PAK 7.1年,PTA 3.3年。
  • 最近时代10年死亡删失胰腺移植物生存率:SPK 86.9%,PAK 58.2%,PTA 47.6%。
  • SPK移植物丢失主要受患者生存影响,PAK和PTA移植物丢失更常因移植物失败。

关键数值与推荐

  • 改善胰腺移植物生存的预测因素:首次移植、外分泌膀胱引流、年轻供者、更短保存时间。

临床怎么用

  • 临床可优先选择首次移植、年轻供者并缩短保存时间以改善胰腺移植物生存。
  • SPK受者需关注患者生存,PAK和PTA受者需重点防范移植物失败。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the evolution of pancreas transplantation, including improved outcomes and factors associated with improved outcomes over the past 5 decades. BACKGROUND: The world's first successful pancreas transplant was performed in December 1966 at the University of Minnesota. As new modalities for diabetes treatment mature, we must carefully assess the current state of pancreas transplantation to determine its ongoing role in patient care. METHODS: A single-center retrospective review of 2500 pancreas transplants was performed over >50 years in bivariate and multivariable models. Transplants were divided into 6 eras; outcomes are presented for the entire cohort and by era. RESULTS: All measures of patient and graft survival improved progressively through the 6 transplant eras. The overall death-censored pancreas graft half-lives were >35 years for simultaneous pancreas and kidney (SPK), 7.1 years for pancreas after kidney (PAK), and 3.3 years for pancreas transplants alone (PTA). The 10-year death-censored pancreas graft survival rate in the most recent era was 86.9% for SPK recipients, 58.2% for PAK recipients, and 47.6% for PTA. Overall, graft loss was most influenced by patient survival in SPK transplants, whereas graft loss in PAK and PTA recipients was more often due to graft failures. Predictors of improved pancreas graft survival were primary transplants, bladder drainage of exocrine secretions, younger donor age, and shorter preservation time. CONCLUSIONS: Pancreas outcomes have significantly improved over time through sequential, but overlapping, advances in surgical technique, immunosuppressive protocols, reduced preservation time, and the more recent reduction of immune-mediated graft loss.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Finger EB, Matar AJ, Dunn TB, et al. Evolution of Pancreas Transplantation At A Single Institution-50+ Years and 2500 Transplants. Ann Surg. 2024. PMID: 38916985. doi:10.1097/SLA.0000000000006415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。